Companies / Belgium
Abbott Loses Patent Case To Innogenetics
September 2006 | Legal NewsIn a victory for small, innovative biotechnology companies, a US federal jury has awarded Belgian biotech firm Innogenetics US$7mn in damages after determining that US-based Abbott Laboratories infringed one of its key
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
